Entera Bio (ENTX) EBT Growth (1y) (2022 - 2026)
Entera Bio (ENTX) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Entera Bio |
56.59 Mn |
52.45 Mn |
- |
-38.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
-38.08% |
| Dec 31, 2025 |
-29.22% |
| Sep 30, 2025 |
-9.24% |
| Jun 30, 2025 |
-22.73% |
| Mar 31, 2025 |
-24.30% |
| Dec 31, 2024 |
-17.49% |
| Sep 30, 2024 |
-28.55% |
| Jun 30, 2024 |
5.38% |
| Mar 31, 2024 |
5.84% |
| Dec 31, 2023 |
35.25% |
| Sep 30, 2023 |
18.20% |
| Jun 30, 2023 |
27.09% |
| Mar 31, 2023 |
42.23% |
| Dec 31, 2022 |
25.13% |
| Sep 30, 2022 |
10.97% |
| Jun 30, 2022 |
-22.94% |
| Mar 31, 2022 |
-64.11% |
